Archives for September 14, 2006

← 2006

More Pfizer plants axed as restructuring continues

By  Gregory Roumeliotis

Pfizer's manufacturing reforms have claimed more casualties in two North American plants as the world's largest drugmaker battles to realign production capacity with future product mix, new technologies and cost effectiveness.

Whole-virus formulation leads to dose-sparing H5N1 vaccine

By  Gregory Roumeliotis

Chinese researchers may have solved the problem of vaccine shortage in the event of an avian influenza pandemic after a clinical trial showed that their formulation containing the whole H5N1 virus instead of virus particles resulted in an affective...

CROs to benefit from new trial analysis technique

By  Wai Lang Chu

Contract Research Organisations (CRO) involved in clinical trial services may benefit from a new technique that allows researchers to statistically analyse results of clinical trials.

New EU initiative to support small biotech firms

By Emilie Reymond

The European Union (EU) has been criticised for being more favourable to big biotech companies, at the expense of smaller firms, according to consultants within the industry.